May 23 (Reuters) - ** Shares of vaccine maker Novavax edge up ~0.4% to $15.70
** Brokerage B. Riley raises PT to $29 from $11
** New PT represents ~84% upside to stock's last close of $46.76
** Out of 6 analysts covering NVAX stock, 3 rate "buy" or higher, 3 "hold"; median PT of $19 - LSEG
** Including session's move, stock is up ~229.3% YTD
(Reporting by Jaiveer Singh Shekhawat in Bengaluru)
((JaiveerSingh.Shekhawat@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments